HighTower Advisors, LLC - PROVECTUS BIOPHARMACEUTICALS ownership

PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 44 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of PROVECTUS BIOPHARMACEUTICALS
ValueSharesWeighting
Q3 2016$6,000
-72.7%
57,9000.0%0.00%
Q2 2016$22,0000.0%57,900
+1.0%
0.00%
Q1 2016$22,0000.0%57,300
+3.3%
0.00%
Q4 2015$22,000
-31.2%
55,4500.0%0.00%
Q3 2015$32,000
+6.7%
55,4500.0%0.00%
Q2 2015$30,000
+3.4%
55,450
+56.4%
0.00%
Q1 2015$29,000
+3.6%
35,4500.0%0.00%
Q4 2014$28,00035,4500.00%
Other shareholders
PROVECTUS BIOPHARMACEUTICALS shareholders Q1 2016
NameSharesValueWeighting ↓
HOME FEDERAL BANK OF TENNESSEE 100,000$6,0000.00%
LEE DANNER & BASS INC 50,000$3,0000.00%
Ancora Advisors LLC 14,650$1,0000.00%
Diversified Trust Co 50,000$3,0000.00%
CAPTRUST FINANCIAL ADVISORS 57,659$3,0000.00%
ACADEMY CAPITAL MANAGEMENT INC/TX 20,000$1,0000.00%
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of PROVECTUS BIOPHARMACEUTICALS shareholders